Woodline Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.94M | Buy |
273,251
+4,789
| +2% | +$174K | 0.05% | 437 |
|
|
2025
Q1 | $9.72M | Sell |
268,462
-1,094
| -0.4% | -$39.6K | 0.06% | 367 |
|
|
2024
Q4 | $11.3M | Buy |
269,556
+2,001
| +0.7% | +$84.2K | 0.08% | 312 |
|
|
2024
Q3 | $14.9M | Buy |
267,555
+765
| +0.3% | +$42.5K | 0.13% | 228 |
|
|
2024
Q2 | $11M | Sell |
266,790
-133,334
| -33% | -$5.48M | 0.1% | 236 |
|
|
2024
Q1 | $18.7M | Hold |
400,124
| – | – | 0.17% | 180 |
|
|
2023
Q4 | $19.1M | Buy |
400,124
+194,641
| +95% | +$9.31M | 0.21% | 146 |
|
|
2023
Q3 | $7.33M | Sell |
205,483
-31,081
| -13% | -$1.11M | 0.09% | 256 |
|
|
2023
Q2 | $10.9M | Buy |
+236,564
| New | +$10.9M | 0.13% | 195 |
|